Ecthyma gangrenosum is a distinctive and often alarming skin condition in which patches of skin rapidly progress from red or purplish spots into black, necrotic ulcers. It is most strongly associated with Pseudomonas aeruginosa infection and overwhelmingly affects people whose immune systems are severely weakened, though it can occasionally appear in otherwise healthy individuals. The condition carries a mortality rate of roughly a third in some cohorts, making early recognition a matter of genuine urgency.
What the Lesions Look Like
The hallmark of ecthyma gangrenosum is a painless or slightly tender macule, often reddish or violaceous, that evolves rapidly over hours to days. It develops a central area of hemorrhagic blistering or induration, which then breaks down into a necrotic ulcer covered by a black eschar, the thick, dry crust of dead tissue. The surrounding skin is typically erythematous, with a halo of redness that gives way to the dark, gangrenous center. Some patients develop a single lesion; others develop scattered lesions at multiple sites simultaneously.
The lesions tend to favor certain body areas. The gluteal and perineal regions are classically involved, along with the extremities and trunk. Genital involvement has been reported, as have periorbital lesions in infants. One case report described a periocular lesion that, left unchecked, had the potential to erode into the nasal bone, lacrimal bone, ethmoid, and maxillary sinus.1IDCases. Periocular ecthyma gangrenosum with Pseudomonas septicemia in an infant: A case report That kind of deep tissue destruction illustrates why these wounds need aggressive attention even when the overlying skin damage looks localized.
The Organisms Behind It
Pseudomonas aeruginosa is the dominant pathogen. A review of published cases found Pseudomonas in about 74% of ecthyma gangrenosum cases.2PubMed. Ecthyma gangrenosum and ecthyma-like lesions: review article This bacterium thrives in moist environments, is notoriously resistant to many antibiotics, and has a particular affinity for damaging blood vessel walls, which drives the tissue death at the core of every lesion.
But Pseudomonas is not the only culprit. Ecthyma gangrenosum-like lesions have been documented with a range of other gram-negative bacteria, gram-positive organisms, and even fungi. Case reports describe the condition arising from Escherichia coli, Citrobacter freundii, Klebsiella species, Staphylococcus aureus, and Stenotrophomonas maltophilia, among others.3PubMed. Nonpseudomonal ecthyma gangrenosum A report of ecthyma gangrenosum caused by Fusarium solani, a mold, underscores that fungal infections should not be dismissed as a potential cause, particularly in patients who fail to respond to antibacterial treatment.4PubMed Central. Ecthyma Gangrenosum of Fungal Origin: A Case Report This matters because identifying the wrong organism leads to the wrong treatment, and with ecthyma gangrenosum, delays are measured in worsening tissue loss.
How the Skin Breaks Down
The underlying mechanism is a form of occlusive vasculitis, meaning the bacteria (or fungi) invade the walls of small blood vessels in the skin, causing clotting and blockage. Once blood flow is cut off, the tissue downstream dies. That ischemic necrosis is what produces the characteristic black eschar. The process can begin in two distinct ways. In some patients, bacteria seed the skin from the bloodstream during sepsis, and the skin lesions are a secondary manifestation of a systemic infection. In others, the organism enters the skin directly through a local break, and the lesion develops as a primary infection that may or may not progress to bacteremia. A study of eight patients found both pathways operating: two patients developed skin lesions after Pseudomonas bacteremia, while two others showed no bacteremia at all, and in a further two, the bloodstream infection appeared to have spread outward from the skin rather than the other way around.5ScienceDirect. The pathogenesis of ecthyma gangrenosum
This two-way relationship between the skin and the bloodstream has real clinical consequences. Clinicians cannot assume that a patient with ecthyma gangrenosum must be bacteremic, nor can they assume that a localized-looking lesion will stay localized.
Who Is at Risk
The classic patient is someone with a severely compromised immune system. Conditions that strongly predispose to ecthyma gangrenosum include neutropenia (very low white blood cell counts), hematologic malignancies such as leukemia or lymphoma, patients undergoing chemotherapy, people living with HIV, those on immunosuppressive therapy after organ transplants, severe burn patients, and people with poorly controlled diabetes or significant malnutrition.6PubMed Central. Ecthyma Gangrenosum of Scrotum in a Patient with Neutropenic Fever: A Case Report Agammaglobulinemia and aplastic anemia are also documented risk factors.7Archives of Clinical Infectious Diseases. Ecthyma gangrenosum Due to Escherichia coli Bacteremia in a Patient with Acute Myeloid Leukemia
The common thread across all of these conditions is that the body’s ability to fight off bacterial invasion is severely weakened. Without functioning neutrophils to swarm and kill bacteria at the site of infection, organisms like Pseudomonas can invade blood vessel walls with little resistance.
When It Appears in Healthy People
Perhaps the most unsettling aspect of ecthyma gangrenosum is that it does not always confine itself to the immunocompromised. Reports of previously healthy children presenting with ecthyma gangrenosum exist, and while uncommon, they challenge the assumption that a normal immune system provides reliable protection.8PubMed. Ecthyma gangrenosum skin lesions in previously healthy children In some of these pediatric cases, the children had no detectable underlying immunodeficiency at all, suggesting that transient or subtle immune vulnerabilities, perhaps from a concurrent viral illness, could occasionally create a window for the organism to establish itself.
Adults without known immune problems have also developed the condition. A case of ecthyma gangrenosum in a previously healthy man, without bacteremia, demonstrated that the condition can arise even when the patient does not fit the classic risk profile.9PubMed Central. Ecthyma gangrenosum without bacteremia in a previously healthy man: a case report These cases are uncommon enough that they still make it into case-report journals, but they serve as a reminder that clinicians should not rule out ecthyma gangrenosum solely because a patient appears otherwise well.
Bacteremic Versus Non-Bacteremic Forms and Why It Matters
Whether the causative organism is circulating in the bloodstream has a major impact on survival. Patients with Pseudomonas bacteremia and ecthyma gangrenosum have been reported to have a mortality rate of about 38%. In contrast, a review of 13 non-bacteremic patients with ecthyma gangrenosum found that only about 15% died. A separate study calculated mortality at roughly 7.5% when the skin lesions were considered the primary infection versus 20% when they were secondary to bacteremia.10PubMed Central. Ecthyma gangrenosum without bacteremia in a previously healthy man: a case report
An early review of non-bacteremic ecthyma gangrenosum noted that these patients closely resembled the classic bacteremic presentation in terms of being immunocompromised and neutropenic, and in terms of where the skin lesions appeared. The striking difference was the much lower mortality rate.11PubMed. Ecthyma gangrenosum without bacteremia. Report of six cases and review of the literature. This suggests that the blood vessel invasion and skin necrosis, while frightening, are more survivable when the infection remains localized. Once Pseudomonas is free in the bloodstream, the risk of multi-organ failure and septic shock climbs steeply.
For clinicians, this distinction is critical at the bedside. Blood cultures drawn at the time ecthyma gangrenosum is identified help stratify risk and guide how aggressively to escalate treatment. Patients whose cultures come back negative can still be seriously ill, but their odds are meaningfully better.
Mortality and What Drives It
A single-institution cohort study found an overall mortality rate of approximately 34% among patients with ecthyma gangrenosum. Neither the specific pathogen responsible nor the location of the lesions on the body was significantly associated with the likelihood of death. What did predict a worse outcome was whether the patient was septic or immunocompromised: patients in either of those categories died more frequently than those who were not.12PubMed. Clinicopathologic features of ecthyma gangrenosum: a single integrated health system cohort
This is worth pausing on. It means the danger comes less from the skin wounds themselves and more from the systemic state of the patient. A person with ecthyma gangrenosum who is septic and profoundly neutropenic is in critical condition; a person with a localized lesion and no bloodstream infection is in a much more manageable situation. One study went so far as to note that even in healthy patients, the condition carries a high mortality rate, and that early diagnosis combined with aggressive antibiotic therapy is imperative.13PubMed Central. Ecthyma gangrenosum: a report of eight cases The urgency is not a formality. These wounds can progress from minor-appearing spots to extensive necrosis in a day or two.
Treatment Strategy
Management centers on two pillars: systemic antibiotics targeted at the causative organism and surgical intervention for the necrotic tissue. The antibiotic regimen should cover Pseudomonas aeruginosa empirically until culture results return, following guidelines from infectious disease societies.14Mayo Clinic Proceedings. Peristomal Ecthyma Gangrenosum Mimicking Pyoderma Gangrenosum The regimen typically involves antipseudomonal beta-lactams or carbapenems, often combined with an aminoglycoside or fluoroquinolone for synergy, though the exact choice depends on local resistance patterns and the patient’s renal function.
Surgical debridement of the necrotic tissue is often necessary alongside antibiotics. The rationale is straightforward: dead tissue harbors bacteria that systemic drugs cannot penetrate effectively, and removing it promotes healing and allows topical antimicrobial irrigation.15Advances in Dermatology and Allergology. Ecthyma gangrenosum as a serious complication of Pseudomonas aeruginosa infection in departments of pediatric oncology For progressive lesions, surgical excision is considered essential to prevent further spread and mortality.16PubMed. Surgical strategies in the management of ecthyma gangrenosum in paediatric oncology patients
In some cases, particularly in infants or when lesions sit near delicate structures like the eye, a more conservative debridement approach may be tried first. One case involving a periocular lesion in an infant used daily removal of the eschar with irrigation using fortified antibiotic drops rather than aggressive surgical excision, and the wound healed without reconstructive surgery.17IDCases. Periocular ecthyma gangrenosum with Pseudomonas septicemia in an infant: A case report That said, this conservative path is the exception rather than the rule, and it requires very close monitoring to ensure the infection is not advancing.
When the causative organism is fungal rather than bacterial, the treatment pivot is obvious but easy to miss. If a patient with presumed ecthyma gangrenosum fails to improve on antibiotics, clinicians need to obtain tissue cultures for fungal organisms and switch to antifungal therapy accordingly.
Granulocyte Transfusions and Other Adjuncts
Standard antibiotics and surgery are sometimes not enough, particularly in patients with profound, prolonged immune deficiency. In one striking case, a patient with leukocyte adhesion deficiency developed Fusarium-related ecthyma gangrenosum that persisted for 18 months despite targeted antibiotics and antifungal therapy. The lesion finally resolved only after massive granulocyte transfusions combined with granulocyte colony-stimulating factor (G-CSF), a drug that stimulates white blood cell production.18PubMed Central. Successful treatment of Fusarium solani ecthyma gangrenosum in a patient affected by leukocyte adhesion deficiency type 1 with granulocytes transfusions
Granulocyte transfusions essentially lend the patient someone else’s white blood cells temporarily. The logic is sound: if the patient’s own immune system cannot mount a response at the infection site, donor granulocytes can fill the gap. This approach is not routine and carries its own risks, including transfusion reactions and alloimmunization, but it offers a last-resort option when antimicrobial therapy alone cannot clear the infection in a severely immunocompromised host.
The Growing Problem of Drug-Resistant Organisms
As with many infections in critically ill patients, multidrug resistance complicates the picture. Case series have documented ecthyma gangrenosum caused by multidrug-resistant gram-negative bacteria in leukemia patients with prolonged neutropenia, requiring combination antibiotic regimens to achieve control.19Infectious Diseases in Clinical Practice. Ecthyma Gangrenosum Secondary to Multidrug-Resistant Gram-Negative Rod Infections in Leukemia Patients With Prolonged Neutropenia The challenge is compounded by the fact that delayed diagnosis is common: ecthyma gangrenosum is rare enough that it is not always recognized promptly, and by the time cultures reveal a resistant organism, the window for optimal early treatment has narrowed.20Infectious Diseases in Clinical Practice. Ecthyma Gangrenosum: A Multidrug-Resistant Gram-Negative Bacilli—A Growing Fear in the Immunocompromised Patients: A Case Series
In one series, three out of four neutropenic patients who developed ecthyma gangrenosum had multidrug-resistant Pseudomonas aeruginosa as the causative organism. When the first-line antipseudomonal agents fail, clinicians are forced into less familiar territory: newer beta-lactam/beta-lactamase inhibitor combinations, polymyxins, or ceftolozane-tazobactam, depending on the susceptibility profile. Awareness of local resistance patterns and early, aggressive culturing of tissue from the lesion are the best tools for avoiding a fatal mismatch between pathogen and antibiotic.
Distinguishing Ecthyma Gangrenosum from Conditions That Look Similar
The black, necrotic ulcers of ecthyma gangrenosum are visually dramatic but not unique. Several other conditions can produce gangrenous-looking skin lesions, and telling them apart determines whether a patient gets antibiotics or immunosuppressants, two treatments that are nearly opposite in their logic.
The most commonly confused condition is pyoderma gangrenosum. Both produce destructive ulcers with dark eschar. The critical difference is that pyoderma gangrenosum is a noninfectious neutrophilic dermatosis, a condition where the immune system attacks the skin without any microbial trigger, while ecthyma gangrenosum is an infectious occlusive vasculitis driven by an invading organism.21British Journal of Dermatology. Pyoderma gangrenosum complicated by ecthyma gangrenosum Treating pyoderma gangrenosum typically involves corticosteroids and immunosuppressive drugs, which would be catastrophic for a patient with ecthyma gangrenosum, amplifying the very immune failure that allowed the infection to take hold. Conversely, surgically debriding pyoderma gangrenosum can worsen it, through a phenomenon called pathergy, where trauma triggers new lesion formation.
A skin biopsy with tissue culture is the most reliable way to distinguish the two. If bacteria or fungi are found invading blood vessel walls, the diagnosis points toward ecthyma gangrenosum. If the biopsy shows dense neutrophilic infiltrates without organisms, pyoderma gangrenosum is more likely. In practice, some patients have both: pyoderma gangrenosum that becomes secondarily infected with Pseudomonas and develops features of ecthyma gangrenosum on top of the underlying immune-mediated process. These overlap cases are rare but extraordinarily difficult to manage.
Other conditions in the differential include calciphylaxis in patients with renal disease, warfarin-induced skin necrosis, necrotizing fasciitis, and various vasculitides. Each has distinguishing clinical and histologic features, but in an immunocompromised patient with rapidly enlarging necrotic ulcers and a positive blood culture, ecthyma gangrenosum should sit high on the list until proven otherwise.
Ecthyma Gangrenosum in Pediatric Oncology
Children undergoing chemotherapy for leukemia and other hematologic cancers represent a particularly vulnerable group. Their neutrophil counts often drop to near zero during treatment cycles, leaving them defenseless against organisms that healthy skin would normally repel. Ecthyma gangrenosum has been described as a serious complication in pediatric oncology departments, where Pseudomonas exposure can occur through contaminated water sources, indwelling catheters, or skin breaks at injection sites.22Advances in Dermatology and Allergology. Ecthyma gangrenosum as a serious complication of Pseudomonas aeruginosa infection in departments of pediatric oncology
Surgical management in children requires particular care. In pediatric oncology patients with progressive lesions, surgical excision is considered essential to prevent mortality, but the extent of surgery must be balanced against the child’s fragile state, the risk of poor wound healing in a neutropenic patient, and the cosmetic and functional consequences of wide excisions.23PubMed. Surgical strategies in the management of ecthyma gangrenosum in paediatric oncology patients Some centers use staged debridement, removing tissue in increments as the antibiotic therapy takes hold and neutrophil counts recover, rather than attempting a single definitive excision during the nadir of the child’s immune function.
For parents and caregivers, awareness of what early lesions look like can make a genuine difference. A new, painless, reddish-purple spot on a neutropenic child’s skin that darkens or blisters over hours warrants urgent medical evaluation, not a wait-and-see approach. The speed at which ecthyma gangrenosum progresses means that even a 12-hour delay in presenting to a hospital can translate into significantly more tissue loss and a harder fight against the infection.